Congenital melanocytic nevi: Where are we now? Part II. Treatment options and approach to treatment

Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision, der...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2012-10, Vol.67 (4), p.515-527
Main Authors: IBRAHIMI, Omar A, ALIKHAN, Ali, EISEN, Daniel B
Format: Article
Language:English
Subjects:
Biological and medical sciences
Dermatology
Education, Medical, Continuing
Humans
Medical sciences
Nevus, Pigmented - congenital
Nevus, Pigmented - surgery
Nevus, Pigmented - therapy
Skin Neoplasms - congenital
Skin Neoplasms - surgery
Skin Neoplasms - therapy
Tumors of the skin and soft tissue. Premalignant lesions
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision, dermabrasion, curettage, chemical peels, radiation therapy, cryotherapy, electrosurgery, and lasers. Only low-level evidence supporting these approaches is available, and large randomized controlled trials have not been published. This article explores therapeutic controversies and makes recommendations based on the best available evidence.
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2012.06.022